Association of lipoprotein lipase gene polymorphisms with coronary artery disease.

[1]  J. Carlquist,et al.  Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women. , 1998, Journal of the American College of Cardiology.

[2]  J. Carlquist,et al.  A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. , 1997, Journal of the American College of Cardiology.

[3]  A. Zwinderman,et al.  The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. , 1996, Circulation.

[4]  M. Hayden,et al.  Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. , 1996, The New England journal of medicine.

[5]  D. Wilcken,et al.  Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. , 1996, Circulation.

[6]  O. Faergeman,et al.  Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. , 1995, Circulation.

[7]  D. Arveiler,et al.  Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde. , 1995, Journal of lipid research.

[8]  J. Buring,et al.  Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. , 1995, JAMA.

[9]  J. Carlquist,et al.  Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. , 1995, Journal of the American College of Cardiology.

[10]  M. Savolainen,et al.  DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. , 1995, Atherosclerosis.

[11]  J M Lalouel,et al.  Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. , 1995, Circulation.

[12]  A. Tall.  Plasma lipid transfer proteins. , 1995, Annual Review of Biochemistry.

[13]  S. Humphries,et al.  Associations of genotypes at the apolipoprotein AI‐CIII‐AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses , 1994, Clinical genetics.

[14]  P. Elwood,et al.  DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  D. Wilcken,et al.  Determinants of severity of coronary artery disease in Australian men and women. , 1994, Circulation.

[16]  R. Ward,et al.  Apolipoprotein Polymorphisms Fail to Define Risk of Coronary Artery Disease: Results of a Prospective, Angiographically Controlled Study , 1994, Circulation.

[17]  R. Frants,et al.  Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. , 1993, The Journal of biological chemistry.

[18]  R. Hamman,et al.  Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. , 1993, Journal of lipid research.

[19]  S. Humphries,et al.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. , 1992, Atherosclerosis.

[20]  J. K. Dunn,et al.  Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  S. Santamarina-Fojo.  Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein C-ll , 1992 .

[22]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Galton,et al.  Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. , 1990, Atherosclerosis.

[24]  D. Galton,et al.  DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. , 1989, Atherosclerosis.

[25]  R. Eckel,et al.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. , 1989, The New England journal of medicine.

[26]  J. Brunzell.  Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome , 1989 .

[27]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[28]  A. Lusis.  Genetic factors affecting blood lipoproteins: the candidate gene approach. , 1988, Journal of lipid research.

[29]  T. Mohandas,et al.  Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. , 1987, Genomics.

[30]  T. Kirchgessner,et al.  Human lipoprotein lipase complementary DNA sequence. , 1987, Science.

[31]  T McLellan,et al.  Genetic distances between the Utah Mormons and related populations. , 1984, American journal of human genetics.

[32]  Cass Principal Investigators and Their Associates.  Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. , 1984, The New England journal of medicine.

[33]  B. Gendel,et al.  MEDICAL GENETICS. , 1963, Memphis and Mid-South medical journal.